Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cardiol Therapeutics (CRDL – Research Report) and MicroPort Scientific (MCRPF – Research Report).
Cardiol Therapeutics (CRDL)
H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Cardiol Therapeutics today and set a price target of $9.00. The company’s shares closed last Monday at $2.18, close to its 52-week high of $2.24.
According to TipRanks.com, Bernardino is a 4-star analyst with an average return of
Currently, the analyst consensus on Cardiol Therapeutics is a Moderate Buy with an average price target of $7.50.
See the top stocks recommended by analysts >>
MicroPort Scientific (MCRPF)
DBS analyst Nico Chen downgraded MicroPort Scientific to Hold today and set a price target of HK$7.30. The company’s shares closed last Thursday at $0.93, close to its 52-week low of $0.70.
According to TipRanks.com, Chen is a 2-star analyst with an average return of
Currently, the analyst consensus on MicroPort Scientific is a Hold with an average price target of $0.98, which is a 5.4% upside from current levels. In a report issued on May 3, Morgan Stanley also maintained a Hold rating on the stock with a HK$9.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on CRDL:
